Four ethical priorities for neurotechnologies and AI R Yuste, S Goering, BA Arcas, G Bi, JM Carmena, A Carter, JJ Fins, ... Nature 551 (7679), 159-163, 2017 | 490 | 2017 |
The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises? W Hall, A Carter, C Forlini The Lancet Psychiatry 2 (1), 105-110, 2015 | 397 | 2015 |
The relationship between weight stigma and eating behavior is explained by weight bias internalization and psychological distress KS O'Brien, JD Latner, RM Puhl, LR Vartanian, C Giles, K Griva, A Carter Appetite 102, 70-76, 2016 | 357 | 2016 |
A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study M Yücel, E Oldenhof, SH Ahmed, D Belin, J Billieux, H Bowden‐Jones, ... Addiction 114 (6), 1095-1109, 2019 | 252 | 2019 |
The neurobiology of “food addiction” and its implications for obesity treatment and policy A Carter, J Hendrikse, N Lee, M Yücel, A Verdejo-Garcia, ZB Andrews, ... Annual review of nutrition 36 (1), 105-128, 2016 | 165 | 2016 |
Neuroethics questions to guide ethical research in the international brain initiatives J Amadio, GQ Bi, PF Boshears, A Carter, A Devor, K Doya, H Garden, ... Neuron 100 (1), 19-36, 2018 | 152 | 2018 |
I miss being me: Phenomenological effects of deep brain stimulation F Gilbert, E Goddard, JNM Viaña, A Carter, M Horne AJOB neuroscience 8 (2), 96-109, 2017 | 143 | 2017 |
Mobile phones in research and treatment: ethical guidelines and future directions A Carter, J Liddle, W Hall, H Chenery JMIR mHealth and uHealth 3 (4), e4538, 2015 | 143 | 2015 |
Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field P Ambermoon, A Carter, WD Hall, NNW Dissanayaka, JD O'Sullivan Addiction 106 (2), 283-293, 2011 | 137 | 2011 |
Drug and alcohol treatment providers’ views about the disease model of addiction and its impact on clinical practice: A systematic review AI Barnett, W Hall, CL Fry, E Dilkes‐Frayne, A Carter Drug and alcohol review 37 (6), 697-720, 2018 | 120 | 2018 |
Addiction neuroethics: The promises and perils of neuroscience research on addiction A Carter, W Hall Cambridge University Press, 2011 | 111* | 2011 |
How is acceptance of the brain disease model of addiction related to Australians’ attitudes towards addicted individuals and treatments for addiction? C Meurk, A Carter, B Partridge, J Lucke, W Hall BMC psychiatry 14, 1-10, 2014 | 98 | 2014 |
Why Don’t Smokers Want Help to Quit? A Qualitative Study of Smokers’ Attitudes towards Assisted vs. Unassisted Quitting K Morphett, B Partridge, C Gartner, A Carter, W Hall International Journal of Environmental Research and Public Health 12 (6 …, 2015 | 94 | 2015 |
Caveolin-1 is required for lateral line neuromast and notochord development SJ Nixon, A Carter, J Wegner, C Ferguson, M Floetenmeyer, J Riches, ... Journal of cell science 120 (13), 2151-2161, 2007 | 83 | 2007 |
The relationship between gambling advertising and gambling attitudes, intentions and behaviours: A critical and meta-analytic review A Bouguettaya, D Lynott, A Carter, O Zerhouni, S Meyer, I Ladegaard, ... Current opinion in behavioral sciences 31, 89-101, 2020 | 80 | 2020 |
Public views on food addiction and obesity: implications for policy and treatment NM Lee, J Lucke, WD Hall, C Meurk, FM Boyle, A Carter PloS one 8 (9), e74836, 2013 | 77 | 2013 |
Realising the technological promise of smartphones in addiction research and treatment: an ethical review H Capon, W Hall, C Fry, A Carter International Journal of Drug Policy 36, 47-57, 2016 | 76 | 2016 |
Ethics of digital mental health during COVID-19: crisis and opportunities N Martinez-Martin, I Dasgupta, A Carter, JA Chandler, P Kellmeyer, ... JMIR Mental Health 7 (12), e23776, 2020 | 65 | 2020 |
Hooked on gambling: A problem of human or machine design? M Yücel, A Carter, K Harrigan, RJ van Holst, C Livingstone The Lancet Psychiatry, 2018 | 64 | 2018 |
Views of Addiction Neuroscientists and Clinicians on the Clinical Impact of a ‘Brain Disease Model of Addiction’ S Bell, A Carter, R Mathews, C Gartner, J Lucke, W Hall | 64 | 2013 |